AXL and breast cancer: In this study, we examined the potential of DN10764 as an AXL inhibitor, based on publicly available data from the LINCS KINOMEscan screen project, and found that DN10764 interfered with AXL-mediated cellular events such as cell proliferation, anti-apoptosis, cellular migration and invasion, and in vivo breast cancer metastasis.